Current difficulties
Although European citizens enjoy the same rights and freedoms, they do not enjoy the same health and access to health services. In terms of health, we see that there is a big gap between countries with strong economies in the West and countries in the East.
The rate of premature mortality and that of preventable mortality are usually above the Union average for Eastern countries, where investments in the health system are also lower.
At the European level, a general package of medical benefits is provided for all citizens, and unmet medical needs at Union level are relatively low. Even so, we can see a disproportion between low-income population groups living in isolated rural areas, much more affected by the lack of regular access to medical services, and middle-income and above-average population categories.
Health education differs from country to country, with a higher level of health knowledge in Western countries than in Eastern countries. The latter also have a very low rate of adherence to general screening and prevention programs.
To truly be a Health Union, disparities between Member States’ health systems must be reduced and the European Union must take on the role of guaranteeing equal access to high-quality medical treatment for all citizens.
What can change?
In order to provide a solid basis for any kind of extension of the European Union’s action in the field of health, amendments to the Treaty must also be made in this area. The Union must put health at the heart of all political decisions, with the main focus of action being the prevention of premature death and disability, ensuring equal and equitable access for all citizens
Solidarity in the face of cross-border health challenges
The COVID-19 pandemic has shown us the need for a Union that has the legislative framework in place to enable it to act directly, decisively and promptly to combat various cross-border health hazards it may face, such as communicable diseases, the spread of resistance. antimicrobials or even attacks with biochemical or nuclear weapons.
The European Commission, through its agencies, the European Medicines Agency and the European Center for Disease Prevention and Control, must be able to inspect, with the help of field teams, Member States’ capacities to respond to various health crises and provide support to them to improve the resilience of national health systems.
The establishment of its network of research laboratories to ensure the collection and processing of medical data on its own, under the auspices of the European Center for Disease Prevention and Control, is a necessary step to ensure a Community response to cross-border health hazards.
The need for autonomous health competence at the European level
One of the lessons of the pandemic is that the European Union must be equipped with an autonomous competence on health that does not depend on Article 114 TFEU and a more consistent budget so that European actions have a real impact. The vulnerability of a health system can become the vulnerability of the entire European Union in the event of a crisis. The revision of the Treaties, which would turn the European Union’s objective of protecting human health into an EU competence in this field, would improve the clarity and legitimacy of EU action and achieve the objectives of public health policy.
There is a need for new shared competences that allow for faster decision-making and a minimum standard of health and compliance with health protocols in all Member States. We can talk about the power of field inspection of agencies to check the difficulties faced by national health systems, to help Member States make necessary reforms and to reduce corruption in hospitals. There is a need for a solid European program, such as EU4Health, with an adequate budget, but which must also come with normative power, with conditions and measures that the European Union can take in the event of inaction by the Member States.
Interconnected health systems
New technologies must be used to increase the level of digitization and interconnection of national public health systems, facilitating the transfer of interchangeable medical data between different Member States, as well as the right of European citizens to receive the highest quality treatment in any Member State.
The standardization and simplification of procedures for the authorization of innovative medicines, the evaluation of health technologies, centralized at the European level (HTA), as well as the stimulation of a domestic pharmaceutical industry, are necessary measures to facilitate the process of marketing new medicines and medical technologies in all Member States.
Union of health against chronic diseases
A true Health Union must have as its main objective the protection of the lives of all citizens of the Union, by ensuring a high standard of health services in all Member States, and by strengthening European programs and public health agencies.
The European Union needs competences to be able to directly support Member States in developing resilient national health systems through European programs to combat the financial burden of chronic diseases, such as cancer or cardiovascular disease.
We must ensure equal access to high-quality treatment for all chronically ill people, and the Union must be able to intervene directly in the development of healthcare infrastructure in the lagging Member States.
Combating recurrent drug shortages, as well as the lack of access to innovative treatments, are other major challenges, the solutions of which can be found at the European level, through joint procurement programs for innovative medicines, thus ensuring equal and equitable access for all Member States to new drug therapies.
Porter
I love how you break down complex concepts into understandable and understandable parts. https://shortenurls.euHosea
Awesome post! Your style is very engaging and your opinions are insightful. Thanks for sharing such useful information with us. Keep it up! https://shortenurls.eu